FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Allergy Relief D Recall

Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg, Extended Release…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class II
Reported by FDA
Jun 26, 2019
Recall ID
D-1387-2019
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Allergy Relief D starting Jun 5, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1387-2019 on Jun 26, 2019. Reason: Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit. Status: Terminated.

Why it was recalled

Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

Product description

Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg, Extended Release Tablets, USP, 30-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895. Made in India. UPC 0 50428 39131 0

Lot numbers, UPCs & expiration codes

Lot: GKT0484B, EXP 04/2020

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1387-2019
Classification
Class II
Status
Terminated
Recall initiated
Jun 5, 2019
FDA report date
Jun 26, 2019
Quantity
9528 30 count units
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-1387-2019, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
83025
Address
270 Prospect Plains Rd
Code information
Lot: GKT0484B, EXP 04/2020
Postal code
08512-3605
Report date
Jun 26, 2019
Product type
Drugs
Recall number
D-1387-2019
Classification
Class II
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
9528 30 count units
Termination date
Jan 8, 2021
Reason for recall
Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit
Voluntary / mandated
Voluntary: Firm initiated
Product description
Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg, Extended Release Tablets, USP, 30-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895. Made in India. UPC 0 50428 39131 0
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 5, 2019
Initial firm notification
Letter
Center classification date
Jun 14, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1387-2019, published Jun 26, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls